Appears
Sido IPO will begin immediately , immediately purchased and the message
appears in the company's stock Sido underwriter .Medicinal
and Pharmaceutical Industries PT Sido Appears appointed PT Kresna Graha
Tbk Sekurindo Tbk and PT Mandiri Securities as underwriters effect . Sido will appear shares to the public as much as 1.5 billion shares , or 10 % of capital in place and paid .IPO
price range set at Rp 540-660 per share , resulting in proceeds from
the Initial Public Offering (Initial Public Offering ) Rp810 - 990
billion .In
the allocation of proceeds from Initial Public Offering ( IPO ) , as
many as 56 % are used for working capital , 42 % for operations and
expansion investments .Financial performance Sido AppearsFirst
six months to July 2013 the company produced five major product
categories , namely energy drinks ( Kuku Bima ) as much as 1.2 billion
units , herbal medicine ( Reject Wind ) with a volume of 441.7 million
units of production , sweets and beverages 262.3 million units ,
health drinks ( Alang Sari , Turmeric Acid , Rice Powder , and Ginger
Fragrant ) as many as 37.4 million units , and other products as much as
1.4 million units .While
the contribution of each product to the sales revenue , 43.28 % energy
drinks , herbal 40.81 % , 13.10 % sweets and drinks , health drinks 1.98
% , and other products with a sales contribution of 0.83 % .Total sales up in July 2013 reached Rp 1.39 trillion , up 3.6 percent compared to July 2012 which amounted to 1.34 trillion . Comprehensive income until July 2013 go up 8.9 % to Rp 207.9 billion compared to July of 2012 amounted to Rp190 , 9 billionHere's the schedule appears Sido IPO1 . Book building period took place on 18-29 November 20132 . IPO pricing date of 29 November 2013 .3 . Effective statement from the Financial Services Authority ( FSA ) dated December 5, 20134 . Offering Period dated 9-12 December 20135 . Stock distribution date of December 17, 20136 . Stock listing ( listing ) on the Indonesia Stock Exchange ( IDX ) dated December 18, 2013 .
Subscribe to:
Post Comments (Atom)
0 comments